Celldex Therapeutics to Present at Upcoming Investor Conferences
Rhea-AI Summary
Celldex Therapeutics (NASDAQ:CLDX) has announced its management's participation in two upcoming investor conferences. The company will engage in fireside chats at the following events:
- 2024 Cantor Global Healthcare Conference on Tuesday, September 17th at 8:35 a.m. ET
- TD Cowen's Chronic Urticaria Summit on Friday, September 20th at 10:00 a.m. ET
Live webcasts of these presentations will be accessible on the 'Events & Presentations' page of the 'Investors & Media' section on Celldex's website. Replays will remain available for 90 days after each event, providing investors with extended access to the company's insights and updates.
Positive
- None.
Negative
- None.
News Market Reaction – CLDX
On the day this news was published, CLDX gained 5.77%, reflecting a notable positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
HAMPTON, N.J., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced today that management will participate in fireside chats at two upcoming conferences:
2024 Cantor Global Healthcare Conference on Tuesday, September 17th at 8:35 a.m. ET
TD Cowen's Chronic Urticaria Summit on Friday, September 20th at 10:00 a.m. ET
Live webcasts of the presentations will be available on the "Events & Presentations” page of the "Investors & Media" section of the Celldex website. Replays will be available for 90 days following the event.
About Celldex Therapeutics, Inc.
Celldex is a clinical stage biotechnology company leading the science at the intersection of mast cell biology and the development of transformative therapeutics for patients. Our pipeline includes antibody-based therapeutics which have the ability to engage the human immune system and/or directly affect critical pathways to improve the lives of patients with severe inflammatory, allergic, autoimmune and other devastating diseases. Visit www.celldex.com.
Company Contact
Sarah Cavanaugh
Senior Vice President, Corporate Affairs & Administration
(508) 864-8337
scavanaugh@celldex.com
Patrick Till
Meru Advisors
(484) 788-8560
ptill@meruadvisors.com
FAQ
When is Celldex Therapeutics (CLDX) presenting at the 2024 Cantor Global Healthcare Conference?
What time is Celldex Therapeutics (CLDX) participating in TD Cowen's Chronic Urticaria Summit?
Where can investors watch the live webcasts of Celldex Therapeutics (CLDX) presentations?
How long will the replays of Celldex Therapeutics (CLDX) conference presentations be available?
